New listings steal the thunder

The penultimate week of the calendar year 2015 ended on a positive note with markets gaining about one a quarter percent. Action continued on a frenzied mode in smallcap and midcap space and the record flows in mutual funds this year also add to the pressure on this segment as funds are flowing into these schemes. The week ahead would see some action on NAV propping as the calendar year ends on Thursday the same day as December futures expire.

The winter session of parliament has ended with hardly any legislative business being done. What little was done was either without debate and discussion and some more was sent to various panels. How long do we citizens have to suffer for the follies of the opposition only time will tell?

The PM in the meanwhile made an unscheduled visit to Pakistan and wished their Prime Minister on his birthday and the marriage of his granddaughter. While there may be certain amount of planning behind the event, it has been hailed internationally as a great step towards improving relations between the two countries. While Congress was lost for words and criticised the move, there response was at best muted and one where they were caught off guard.

The primary market had all the action last week where two new listings stole the limelight. Alkem Laboratories which through a secondary offering had sold shares in a price band of Rs 1020-1050 listed at a price of Rs 1380 and went on to gain further on Friday and closed the week at Rs 1521.75, a gain of Rs 471.85 or 44.93%. The other share to list Dr Lal Pathlabs went a step further and against an issue price of Rs 550 closed the week at Rs 893.65, a gain of Rs 343.65 or 62.48%. This clearly makes Dr Lal’s issue the best debut for the year 2015. The other issue which closed for subscription during the week was Narayana Hrudayalaya which was subscribed 8.70 times overall with QIB portion subscribed 24.43 times, HNI 3.62 and Retail 1.89 times. The response could be said to be muted considering the response to Dr Lal and Alkem Labs.

Finally the delisting of Essar Oil seems to be over with the discovered price at Rs 262.80. The floor price as recommended by the company was under Rs 147. There is still one likely sweetener left as the company has to make public the deal with Rosenoft and offer the higher of the discovered price or the deal price with Roseonoft. We are all aware that the Prime Minister was in Moscow to sign the deal with the Russian counterpart involving this very same company. The difference if any would be paid to those shareholders who have tendered in the delisting and would tender in the window which remains open for one year. People who sell in the market in the intervening period will not the advantage if any.

Volatile times to continue amidst thin volumes.

Wishing all a happy and prosperous New Year 2016

Performance of Newly Listed Shares as on 24th December 2015

Name Date of listing Issue Price closing price closing price % gain loss change over
24th December 18th December Over week lssue price
Sadbhav Infrastructure Project Limited 16th September 103.00 97.70 97.40 0.29 -5.15
Prabhat Dairy Limited 21st September 115.00 146.10 151.40 -4.61 27.04
Coffee Day Enterprises Limited 2nd November 328.00 279.40 285.50 -1.86 -14.82
Interglobe Aviation Limited 10th November 765.00 1164.25 1142.75 2.81 52.19
S H Kelkar & Company Limited 16th November 180.00 237.80 241.90 -2.28 32.11
Alkem Laboratories Limited 23rd December 1050.00 1521.75 N A 44.93 44.93
Dr Lal Pathlabs Limited 23rd December 550.00 893.65 N A 62.48 62.48

Dr Lal Pathlabs Limited – Stunning debut Share up 50%

Shares of Dr Pathlabs Limited listed at the BSE and NSE and made a stunning debut to be easily the best listing for the year 2015. The company had through a secondary offering sold 1.16 cr shares in a price band of Rs 540-550 with a discount of Rs 15 to retail investors. The company had allotted 34.80 lac shares to 15 anchor investors comprising of 25 entities at the top end of the band at Rs 550. The issue received excellent response and was subscribed 33.41 times with HNI’s subscribing their bucket 61.28 times.

The discovered price was Rs 717 on the BSE and Rs 720 on the NSE. The lows of the day were quite close to this discovered price at Rs 715.50 and Rs 711.15 respectively. The highs of the day were Rs 842.40 and 843.70. The weighted average was Rs 777.15 and Rs 778.44 significantly lower than the closing price of Rs 824.15 and Rs 834.50. This indicates that the price rise was in the latter half of the day. Apparently looking at the huge trading volumes of 271.87 lac shares or 2.34 times of the IPO size, one gets a feeling that somewhere people/traders went short during the day and this led to short covering and significant increase in traded volume.

Delivery volume at 55.50 lac shares was 20.41% of traded volume and a significant 47.84% of the IPO size. If one were to deduct the anchor portion from the same which has a lock in period of 30 days, the delivery percentage rises significantly to 68.35%. Just one name appears in the bulk trades list with Ashoka PTE buying 4.25 lac shares at 729.86 per share. Very clearly the share has gone into stronger hands and there seems to be some sort of liquidity squeeze on the counter. It’s good for some more price movement but valuations are certainly stretched at these levels.

Exchange  Open  High Low Close Net Change % Gain/loss Wt. Avg Volume Delivery  Del %age
BSE 717.00 842.40 715.50 824.15 274.15 49.85 777.15 4969365 932390 18.76
NSE 720.00 843.70 711.15 834.50 284.50 51.73 778.44 22217904 4617581 20.78
Total 27187269 5549971 20.41

All in all it’s been a super duper listing and with 50% gains on listing day no one can complain. It is a Christmas gift to investors who were lucky and they have made decent gains. Lucky investors from the retail category were allotted 20s shares at a discount of Rs 15 which means they paid Rs 10,700 for 20 shares and were able to sell them at the average price of Rs 777, a profit of Rs 242 or 45%. It sure is a great start.

With clearly the best left for the year end, hopes of money being left on the table will rise with coming issues in the new calendar year. Whether the promoter-merchant banker duo delivers or not will be seen in the next few issues.

Great start for Dr Lal Pathlabs.

Subscribe to RSS Feed Follow me on Twitter!